Isaac J Kaopua Jr, OD | |
98-1247 Kaahumanu St, Suite #116, Aiea, HI 96701-5311 | |
(808) 488-4000 | |
(808) 488-7667 |
Full Name | Isaac J Kaopua Jr |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 40 Years |
Location | 98-1247 Kaahumanu St, Aiea, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104982768 | NPI | - | NPPES |
0000018895 | Other | HI | QUEST |
01759901 | Medicaid | HI | |
1889-5 | Other | HI | HAWAII MEDICAL SERVICE AS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 216 (Hawaii) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Waimanalo Health Center | 8527029198 | 19 |
News Archive
Adults over 65 who have recently begun thiazide diuretics are at a greater risk for developing metabolic-related adverse events, researchers at UT-Southwestern Medical Center have found.
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.
When it comes to health care, Democrats in specific and lawmakers in general will face deep policy differences when they return to work next week.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
› Verified 9 days ago
Provider Name | Waimanalo Health Center |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1780738005 PECOS PAC ID: 8527029198 Enrollment ID: O20041026001073 |
News Archive
Adults over 65 who have recently begun thiazide diuretics are at a greater risk for developing metabolic-related adverse events, researchers at UT-Southwestern Medical Center have found.
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.
When it comes to health care, Democrats in specific and lawmakers in general will face deep policy differences when they return to work next week.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
› Verified 9 days ago
Provider Name | Ophthalmology Consultants Of Oahu Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1528693306 PECOS PAC ID: 4183046543 Enrollment ID: O20200612001824 |
News Archive
Adults over 65 who have recently begun thiazide diuretics are at a greater risk for developing metabolic-related adverse events, researchers at UT-Southwestern Medical Center have found.
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.
When it comes to health care, Democrats in specific and lawmakers in general will face deep policy differences when they return to work next week.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Isaac J Kaopua Jr, OD 98-1247 Kaahumanu St, Suite #116, Aiea, HI 96701-5311 Ph: (808) 488-4000 | Isaac J Kaopua Jr, OD 98-1247 Kaahumanu St, Suite #116, Aiea, HI 96701-5311 Ph: (808) 488-4000 |
News Archive
Adults over 65 who have recently begun thiazide diuretics are at a greater risk for developing metabolic-related adverse events, researchers at UT-Southwestern Medical Center have found.
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.
When it comes to health care, Democrats in specific and lawmakers in general will face deep policy differences when they return to work next week.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
› Verified 9 days ago
Styleyes Optometrist Medicare: Medicare Enrolled Practice Location: 98-150 Kaonohi St, B211, Aiea, HI 96701 Phone: 808-486-3937 Fax: 808-486-3386 | |
Dr. Melanie Keiko Nakashima, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701 Phone: 808-487-5500 Fax: 808-486-2694 | |
Dr. Walter M Yamamoto, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 99-205 Moanalua Rd, Ste 210, Aiea, HI 96701 Phone: 808-487-1010 Fax: 808-488-3433 | |
Mr. Edwin Yoshio Endo Ii, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 98-1247 Kaahumanu St, Suite 105, Aiea, HI 96701 Phone: 808-487-5500 Fax: 808-488-2322 | |
Dr. Walter Gwok Wo Au, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 98-1247 Kaahumanu St Ste 105, Aiea, HI 96701 Phone: 808-487-5500 | |
Marissa Matsuyama, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 99-128 Aiea Heights Dr Ste 703, Aiea, HI 96701 Phone: 808-487-7938 |